US Drug Recall Register

Is Clindamycin recalled?

Yes — there is an active recall. 8 ongoing FDA recalls mention Clindamycin (45 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Clindamycin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Terminated

Clindamycin Injection USP

Reason Lack of Assurance of Sterility

Alvogen, Inc NDC 47781-463-69 D-0940-2017
Class II · Moderate risk Terminated

Clindamycin Injection USP

Reason Lack of Assurance of Sterility

Alvogen, Inc NDC 47781-462-69 D-0939-2017
Class III · Low risk Terminated

Clindamycin Phosphate Topical Solution USP

Reason CGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots.

G & W Laboratories, Inc. NDC 0472-0987-91 D-0519-2017
Class II · Moderate risk Terminated

Clear 2

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0555-2017
Class II · Moderate risk Terminated

Clear

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0554-2017
Class II · Moderate risk Terminated

Acne Solution

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0550-2017
Class II · Moderate risk Terminated

Clindamycin 1%

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0534-2017
Class II · Moderate risk Terminated

Benzoyl Peroxide 5% Clindamycin 1.2%

Reason Lack of Assurance of Sterility: There are also CGMP Deviations.

Synergy Rx D-0531-2017
Class II · Moderate risk Terminated

Clindamycin Phosphate and Benzoyl Peroxide Gel

Reason Microbial Contamination of Non-Sterile Product; small number of tubes may include the presence of mold on the cap

L. Perrigo Company NDC 45802-736-84 D-0434-2017
Class II · Moderate risk Terminated

Clindamycin 900 mg in 100 mL 0.9% NS bag

Reason Lack of Sterility Assurance

Baptist Health Medical Towers Pharmacy and Infusion Services D-0919-2016
Class II · Moderate risk Terminated

Clindamycin injection

Reason Lack of Assurance of Sterility

Walgreens Infusion Services D-0550-2016
Class II · Moderate risk Terminated

CLINDAMYCIN 120MG in NS

Reason Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Sentara Enterprises D-0639-2016
Class II · Moderate risk Terminated

Clindamycin HCl active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-593-2015
Class II · Moderate risk Terminated

Perrigo

Reason Presence of Particulate Matter Perrigo is recalling seven lots of Clindamycin Palmitate Hydrochloride for Oral Solution 75mg/5ml.

Paddock Laboratories, LLC NDC 0574-0129-01 D-1168-2014
Class III · Low risk Terminated

Acanya

Reason Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being carried out due to an incorrect expiration date assigned to a lot of physicians samples.

Valeant Pharmaceuticals North Am NDC 13548-132-03 D-020-2014
Class II · Moderate risk Terminated

Clindamycin HCL

Reason Labeling: Label Mixup: CLINDAMYCIN HCL, Capsule, 300 mg may have potentially been mislabeled as the following drug: MELATONIN, Tablet, 3 mg, NDC 51991001406, Pedigree: AD68019_7, EXP: 5/28/2014.

Aidapak Services, LLC D-969-2014
Class II · Moderate risk Terminated

Cleocin Phosphate

Reason Presence of Particulate Matter: Firm is recalling a small number of vials with very small reflective flakes consistent with delamination of the glass vial.

Pharmacia & Upjohn LLC D-609-2013
Class II · Moderate risk Terminated

Gentamicin 40mg/Ml

Reason Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1528-2012
Class II · Moderate risk Terminated

Clindamycin Ophthalmic

Reason Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1486-2012